Richard N Kender

CIK 1381205 · See Remarks · last filed 2026-03-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$487.1K

Companies

6

Total Filings

30

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MCRB See Remarks 63,492 $5.70 $361.9K $0 14 2026-03-06
LGVN Director 33,000 $0.78 $25.8K $0 2 2025-07-17
BCYC Director 23,000 $4.05 $93.2K $0 7 2025-01-06
Omega Therapeutics, Inc. (OMGA) Delisted Director $0.14 $0 1 2024-06-21
INCR Director 7,148 $0.87 $6.2K $0 4 2017-05-24
ev3 Inc. (EVVV) Delisted Director 324 $0 1 2007-10-09

Recent Filings · Page 2 of 3

30 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-07-06 MCRB Grant (A) +63,492 $200.0K EDGAR
2022-06-24 MCRB Grant (A) $0 EDGAR
2022-06-24 MCRB Grant (A) $0 EDGAR
2022-01-05 BCYC Grant (A) +5,000 $0 EDGAR
2021-06-21 MCRB Grant (A) $0 EDGAR
2021-01-05 BCYC Grant (A) $0 EDGAR
2020-06-22 MCRB Grant (A) $0 EDGAR
2020-01-06 BCYC Grant (A) $0 EDGAR
2019-09-30 BCYC Grant (A) $0 EDGAR
2019-06-14 MCRB Grant (A) $0 EDGAR
Showing 1120 of 30
Page 2 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.